Pathogenetic mechanisms of polycythemia vera and congenital polycythemic disorders
- 31 January 2001
- journal article
- Published by Elsevier in Seminars in Hematology
- Vol. 38, 10-20
- https://doi.org/10.1016/s0037-1963(01)90135-0
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Mechanism of regulation of the hypoxia-inducible factor-1alpha by the von Hippel-Lindau tumor suppressor proteinThe EMBO Journal, 2000
- Hypoxia Inducible Factor-α Binding and Ubiquitylation by the von Hippel-Lindau Tumor Suppressor ProteinJournal of Biological Chemistry, 2000
- Regulation of Mammalian O2Homeostasis by Hypoxia-Inducible Factor 1Annual Review of Cell and Developmental Biology, 1999
- Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1αGenes & Development, 1998
- The gene encoding hematopoietic cell phosphatase (SHP-1) is structurally and transcriptionally intact in polycythemia veraOncogene, 1997
- Primary familial and congenital polycythaemiaThe Lancet, 1993
- JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietinCell, 1993
- Angiotensin II receptor-mediated proliferation of cultured human fetal mesangial cellsKidney International, 1991
- Erythropoietin Retards DNA Breakdown and Prevents Programmed Death in Erythroid Progenitor CellsScience, 1990
- Erythroid colony formation by polycythemia vera bone marrow in vitro. Dependence on erythropoietin.Journal of Clinical Investigation, 1977